To determine whether the adenosine methylation level of miR-125a-5p could be associated with positive or negative response of lung cancer patients treated with anti-PD-1 therapy, we questioned the adenosine methylation level of exosomal miR-125a-5p (m6A-exomiR-125a-5p). This evidence concerns the gene PDCD1 and lung carcinoma.